Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015.

about

Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015.

Item

http://www.wikidata.org/entity/Q51763086

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Increasing co-morbidities in c ...... al practices during 2000-2015.

@en

Increasing co-morbidities in c ...... al practices during 2000-2015.

@nl

type

Item

label

Increasing co-morbidities in c ...... al practices during 2000-2015.

@en

Increasing co-morbidities in c ...... al practices during 2000-2015.

@nl

prefLabel

Increasing co-morbidities in c ...... al practices during 2000-2015.

@en

Increasing co-morbidities in c ...... al practices during 2000-2015.

@nl

P1476

Increasing co-morbidities in c ...... al practices during 2000-2015.

@en

P2093

An Le

http://www.w3.org/2001/XMLSchema#string

Anne Liu

http://www.w3.org/2001/XMLSchema#string

Chris Wong

http://www.w3.org/2001/XMLSchema#string

Clifford Wong

http://www.w3.org/2001/XMLSchema#string

Jian Zhang

http://www.w3.org/2001/XMLSchema#string

Linda Henry

http://www.w3.org/2001/XMLSchema#string

Mindie H Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Nonalcoholic fatty liver disease: a systematic review

Management of hepatocellular carcinoma

Chronic hepatitis B: update 2009

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Criteria and classification of obesity in Japan and Asia-Oceania.

Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis.

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.

P304

141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41424-018-0007-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29540676

http://www.w3.org/2001/XMLSchema#string

P932

5862154

http://www.w3.org/2001/XMLSchema#string